Showing results (61-70 of 180) with videos related to

Sort By:
Pageof 18
International Journal of Pharmaceutics|January 9, 2020
Developing an injectable co-formulation of two antidiabetic drugs: Excipient impact on peptide aggregation and pharmacokinetic propertiesAnne-Laure Lainé, Sophie Houvenagel, Anders Broo, et al.
Protein Engineering, Design & Selection : PEDS|July 3, 2015
Directed evolution of anti-HER2 DARPins by SNAP display reveals stability/function trade-offs in the selection processGillian Houlihan, Pietro Gatti-Lafranconi, David Lowe, et al.
Annals of Emergency Medicine|May 31, 2020
Ondansetron Prescription Is Associated With Reduced Return Visits to the Pediatric Emergency Department for Children With GastroenteritisDoreen Benary, Juan M Lozano, Rebecca Higley, et al.
Methods in Enzymology|February 3, 2009
Lysosomes and autophagy in aquatic animalsMichael N Moore, Angela Kohler, David Lowe, et al.
Otolaryngologia Polska = the Polish Otolaryngology|August 6, 2013
Unilateral non-Hodgkin's lymphoma of the frontal sinus presenting as Pott's puffy tumourEugene H C Wong, Woo-Young Yang, David Lowe
Molecular Cancer|February 15, 2013
Combining phenotypic and proteomic approaches to identify membrane targets in a 'triple negative' breast cancer cell typeSteven Rust, Sandrine Guillard, Kris Sachsenmeier, et al.
Lancet (London, England)|June 28, 2018
MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a studyPhilip Ambery, Victoria E Parker, Michael Stumvoll, et al.
Contemporary Clinical Trials Communications|February 7, 2025
Design and rationale for a global novel non-invasive screening observational study using genetics and non-invasive methodologies to identify at-risk MASLD participants: The ALIGN studySamuel J Daniels, Karin Nelander, John Eriksson, et al.
The Journal of Applied Laboratory Medicine|July 7, 2022
The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating LevelsYanislava Karusheva, Matthew Ratcliff, Alexander Mörseburg, et al.
Diabetes, Obesity & Metabolism|April 2, 2024
Dual glucagon-like peptide-1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesityRajna Golubic, Jane Kennet, Victoria Parker, et al.
Pageof 18